Skip to main content
. 2023 Apr 5;13:1128930. doi: 10.3389/fonc.2023.1128930

Table 3.

Cox model after adjusting for confounding factors on PFS for first-line therapy (N=922).

Characteristic HR (95% CI) p-value
Start of first-line therapy 0.7059
2000-2009 1
2010-2013 0.92 (0.78: 1.09)
2014-2017 1.03 (0.86: 1.23)
Age at first-line therapy 1 (0.99: 1.01) 0.7059
Primary tumor site 0.0092
Intrahepatic 1
Extrahepatic 0.88 (0.74: 1.05)
Gallbladder 1.18 (0.99: 1.41)
Ampullary tumor 0.69 (0.51: 0.94)
Disease status 0.0835
Locally-advanced 1
Metastatic 1.2 (1.02: 1.42)